Pharmacological interventions: SGLT2 inhibitors in diabetic heart failure.
Event: ESC Congress 2021 - The Digital Experience
Topic: Risk Factors and Prevention
Session: Meet the Experts: fuel up! – targeting cardiac energy metabolism in type 2 diabetes and heart failure…
Gut microbiota and its dependent metabolite Trimethylamine N-oxide (TMAO) exacerbate adverse post-infarction left ventricular remodeling.
Event: ESC Congress 2017
Topic: Pathophysiology and diagnosis
Session: Chronic heart failure (CHF)
ESC 365 is supported by
